Axxora Deal Boosts Enzo’s International Distribution

Enzo Biochem, of New York, NY, said yesterday that it would buy Axxora Life Sciences, a private company based in San Diego that makes life sciences research products, for $16.3 million in cash. Once the deal goes through, Axxora will become a wholly owned subsidiary of Enzo’s Enzo Life Sciences...

Telemedicine Addresses Rising Healthcare Costs

A recent article in The New York Times discusses TeleStroke, a telemedicine program being offered by Brigham and Women’s and Massachusetts General Hospitals in Boston. The program is designed to help hospitals that do not have the resources to employ expensive stroke specialists and as a result, are not...

FDA Green Lights Harvest’s Stem Cell Trial

Harvest Technologies, a Plymouth, MA, company that uses stem cells from bone marrow to treat critical limb ischemia, received the go-ahead yesterday from FDA to start a 48-patient trial for the company’s Bone Marrow Aspirate Concentrate (BMAC) System. If all goes as planned, Harvest expects the device...

Next-Generation Psych Treatments

An article published yesterday in Technology Review discusses two new technologies being developed to improve psychiatric treatment. The first, from Norwood, MA-based Aspect Medical Systems, is a device that predicts whether an antidepressant is taking effect, after just one week. Typically, patients have to...

BioElectronics Expands International Distribution

BioElectronics, a Frederick, MD, company that makes anti-inflammatory patches, signed a deal last week with Eximeq for the Mexican healthcare-services provider to distribute BioElectronics’ ActiPatch south of the border. ActiPatch delivers pulsed electromagnetic frequency (PEMF) to accelerate healing of...

Endocare Raises $7 Million

Endocare, an Irvine, CA-based company focused on tissue and tumor ablation, has raised $7 million in a private placement of common stock to Seattle-based Frazier Healthcare Ventures. In a statement, Endocare CEO Craig Davenport said the money will go toward the company’s development efforts in...

New Device Outpaces Competition in Epilepsy Market

A new device for epilepsy patients being developed by Mountain View, CA-based NeuroPace was featured this week in Technology Review. The company’s responsive neurostimulation (RNS) system is designed to help epilepsy patients who are unresponsive to drugs. NeuroPace estimates that about 2.5 million...

Regional Group Supports Pittsburgh Startup

Pittsburgh Life Sciences Greenhouse, an organization that invests in up-and-coming biosciences companies in Southwestern Pennsylvania, has committed $150,000 to Celsense, a local company that was founded in 2005 to commercialize imaging platforms licensed from Carnegie Mellon University. The privately held...